Phosphoglycerate kinase in the treatment of disease
Номер патента: WO2001043767A1
Опубликовано: 21-06-2001
Автор(ы): Angelina J. Lay, Philip John Hogg
Принадлежит: UNISEARCH LIMITED
Опубликовано: 21-06-2001
Автор(ы): Angelina J. Lay, Philip John Hogg
Принадлежит: UNISEARCH LIMITED
Реферат: The present invention provides a pharmaceutical composition for the inhibition of angiogenesis associated with disease in a vertebrate, said composition comprising phosphoglycerate kinase, or a fragment(s) or analogue thereof, together with a pharmaceutically acceptable carrier, adjuvant and/or diluent. The present invention also relates to the treatment of disease, especially cancer, in a vertebrate via the administration of a therapeutically effective amount of phosphoglycerate kinase (PGK), or fragment(s) or analogue thereof.
Anti-renalase antibodies for the treatment and prevention of diseases and disorders
Номер патента: EP3732204A1. Автор: Gary Desir,Bryce Nelson. Владелец: YALE UNIVERSITY. Дата публикации: 2020-11-04.